N@N

Market Maker Surveillance Report. LNG, AMPE, HOV, WAHUQ, ALIM, FNMAP, Losing Stocks With Lowest Price Friction For Tuesday, De

December 13, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 3669 companies with "abnormal" market making, 1676 companies with positive Friction Factors and 4593 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. CHENIERE ENERGY INC (AMEX:LNG), AMPIO PHARMACEUTICALS INC (OTC:AMPE), HOVNANIAN ENTERPRISES-A (NYSE:HOV), Washington Mutual Ut (OTC:WAHUQ), ALIMERA SCIENCES INC (NASDAQ:ALIM), FEDERAL NATIONAL MTG ASSN Non Cum Pfd Ser R 7.625% (OTC:FNMAP). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     LNG        $-1.740      -17.33%      1,039,527       31.41%       1,043,721       31.53%       -4,194          -24     
     AMPE       $-2.370      -32.16%      202,920         40.99%       289,722         58.52%       -86,802         -366    
     HOV        $-0.240      -14.46%      572,603         33.58%       708,882         41.57%       -136,279        -5,678  
     WAHUQ      $-0.540      -18.18%      28,454          10.87%       84,608          32.32%       -56,154         -1,040  
     ALIM       $-0.340      -18.99%      437,394         37.49%       728,269         62.42%       -290,875        -8,555  
     FNMAP      $-0.430      -19.55%      36,600          44.42%       45,800          55.58%       -9,200          -214    

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows LNG with a dollar loss Tuesday of $-1.74000 and a Friction Factor of -24 shares. That means that it only took 24 more shares of selling than buying to move LNG lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

CHENIERE ENERGY INC (AMEX:LNG) - Cheniere Energy, Inc., through its subsidiaries, engages in the development, construction, ownership, and operation of onshore liquefied natural gas (LNG) receiving terminals and natural gas pipelines in the Gulf Coast of the United States. The company develops LNG receiving terminal projects on Sabine Pass LNG in western Cameron Parish, Louisiana on the Sabine Pass Channel; Corpus Christi LNG near Corpus Christi, Texas; Creole Trail LNG at the mouth of the Calcasieu Channel in central Cameron Parish, Louisiana; and Freeport LNG on Quintana Island near Freeport, Texas. It also engages in oil and natural gas exploration and development activities in the Gulf of Mexico. The company was founded in 1983 and is based in Houston, Texas.

AMPIO PHARMACEUTICALS INC (OTC:AMPE) - Ampio Pharmaceuticals, Inc. discovers and develops drugs for metabolic, eye, kidney, inflammation, and central nervous system diseases. The companys principal products include Optina, an oral drug that is in Phase II clinical trials for the treatment of diabetic retinopathy and macular edema; and Vasaloc, an oral drug in Phase II clinical trials for the treatment of diabetic nephropathy. It is also developing DMI-9523, a new molecular entity being developed as a non-steroidal oral drug for the treatment of diseases involving inflammation. Ampio Pharmaceuticals, Inc. was formerly known as DMI Life Sciences, Inc. and changed its name to Ampio Pharmaceuticals, Inc. in March 2010. Ampio Pharmaceuticals, Inc. was founded in 1990 and is based in Greenwood Village, Colorado.

HOVNANIAN ENTERPRISES-A (NYSE:HOV) - Hovnanian Enterprises, Inc. engages in homebuilding and financial services businesses in the United States. The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, mid-rise and high-rise condominiums, urban infill, and active adult homes. It markets and builds homes for first-time buyers, first and second-time move-up buyers, luxury buyers, active adult buyers, and empty nesters. The company offers homes for sale in 192 communities in 40 markets in 18 states in the United States. It also provides various financial services, including originating mortgages from homebuyers and selling such mortgages in the secondary market, as well as offers title insurance services. The company was founded in 1959 and is headquartered in Red Bank, New Jersey.

Washington Mutual Ut (OTC:WAHUQ) - Washington Mutual Ut

ALIMERA SCIENCES INC (NASDAQ:ALIM) - Alimera Sciences, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of ophthalmic pharmaceuticals. It develops pharmaceuticals for diseases affecting the back of the eye or retina. The companys product candidates include Iluvien, an intravitreal insert that provides a sustained therapeutic effect for up to 36 months in the treatment of diabetic macular edema; or DME, a disease of the retina that affects individuals with diabetes and could lead to severe vision loss and blindness, as well as other ophthalmic diseases, such as the wet form of age-related macular degeneration (AMD), the dry form of AMD, and retinal vein occlusion. It also conducts testing on two classes of Nicotinamide Adenine Dinucleotide Phosphate oxidase inhibitors. The company was founded in 2003 and is headquartered in Alpharetta, Georgia.

FEDERAL NATIONAL MTG ASSN Non Cum Pfd Ser R 7.625% (OTC:FNMAP) - FEDERAL NATIONAL MTG ASSN Non Cum Pfd Ser R 7.625%

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net